Showing results (591-600 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|May 17, 2011
Predictive values of 5-fluorouracil pathway genes for S-1 treatment in patients with advanced gastric cancerHei-Cheul Jeung, Sun Young Rha, Sang Joon Shin, et al.
Anti-Cancer Drugs|August 19, 2011
A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, synergistically enhances radiation sensitivity in human cervical cancer cellsSoo-Jung Woo, Min-Jung Kim, Rae-Kwon Kim, et al.
Anti-Cancer Drugs|July 20, 2011
Clinical and radiological response with FOLFOXIRI and bevacizumab as third-line therapy after mFOLFOX6 and FOLFIRI failureJulio Vieira de Melo, Mauro Sérgio Vieira de Melo, Mariana Helena Abad
Anti-Cancer Drugs|July 30, 2011
Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysisIqrar Ali Alvi, Jitender Madan, Dinesh Kaushik, et al.
Anti-Cancer Drugs|August 31, 2011
Weight loss induced by tyrosine kinase inhibitors of the vascular endothelial growth factor pathwayIngrid M E Desar, Annemarie M J Thijs, Sasja F Mulder, et al.
Anti-Cancer Drugs|July 29, 2011
Clinical characterization of patients with metastatic colorectal cancer depending on the KRAS statusDominik P Modest, Sebastian Stintzing, Ruediger P Laubender, et al.
Anti-Cancer Drugs|September 22, 2011
Complete clinical and biological response to zoledronic acid in castrate-resistant prostate cancer metastatic to boneDamien Pouessel, Stéphane Culine
Anti-Cancer Drugs|September 22, 2011
The in-vitro antiproliferative effect of PRI-2191 and imatinib applied in combined treatment with cisplatin, idarubicin, or docetaxel on human leukemia cellsMarta Switalska, Anna Nasulewicz-Goldeman, Aleksandra Opolska, et al.
Anti-Cancer Drugs|October 6, 2011
Wound healing and catheter thrombosis after implantable venous access device placement in 266 breast cancers treated with bevacizumab therapyIrène Kriegel, Paul H Cottu, Virginie Fourchotte, et al.
Anti-Cancer Drugs|October 20, 2011
B1, a novel topoisomerase II inhibitor, induces apoptosis and cell cycle G1 arrest in lung adenocarcinoma A549 cellsMeng-Hsuan Cheng, Yu-Chiao Yang, Yun-Hong Wong, et al.
Pageof 464